6-乙基鹅去氧胆酸
- ·产品类别：中间体/医药中间体
- ·英文名称：(3alpha,5beta,6alpha,7alpha)-6-Ethyl-3,7-dihydroxycholan-24-oic acid
- ·CAS NO：459789-99-2
- ·分子量：420.6252
- ·EC NO：暂无数据
- ·分子式：C26H44O4
- ·InChI：InChI=1/C26H44O4/c1-5-17-21-14-16(27)10-12-26(21,4)20-11-13-25(3)18(15(2)6-9-22(28)29)7-8-19(25)23(20)24(17)30/h15-21,23-24,27,30H,5-14H2,1-4H3,(H,28,29)/t15-,16-,17-,18-,19+,20+,21+,23+,24-,25-,26-/m1/s1
- ·规格：98%
- ·包装：100g/bag, 1kg/bag, 5kg/drum, 25kg/drum
- ·产品介绍：We are the first company in domestic to approach this product at the moment.
Sample is available on Mid-Oct, 2014.
Good service, your good business partner.
Other Drug Names: OCA, Intercept; DSP-1747; FXR agonists, Intercept; INT-747; farnesoid X
receptor agonists, Intercept; 6ECDCA; UPF-747; obeticholic acid： OCA, Intercept; DSP-1747; FXR agonists, Intercept; INT-747; farnesoid Xreceptor agonists, Intercept; 6ECDCA; UPF-747; obeticholic acid
Innovator: Intercept Pharmaceuticals Inc; Sumitomo Dainippon Pharma Co Ltd
Inactive Companies： Universita di Perugia
Sep, 2014, highest status: Phase 3 Clinical
Active Indication: Liver disease; Primary sclerosing cholangitis; Alcoholic hepatitis; Primary biliary
cirrhosis; Diarrhea; Portal hypertension; Non-alcoholic steatohepatitis
Inactive Indications:Jaundice;Non alcoholic fatty liver disease
Farnesoid X receptor agonist
Other Actions: Anti-inflammatory; Bile acid modulator
Technologies: Oral formulation; Small molecule therapeutic
- ·用途：R&D, intermediates.
- ·别名：奥贝胆酸;6-乙基鹅脱氧胆酸;6α-乙基-3α,7α-二羟基-5β-胆甾烷-24-酸;6α-乙基-3α,7α-二羟基-5β-胆烷酸
- ·结构式：
- 联系方式
- 公司名称：上海祥耕科技发展有限公司
- E-mail ：chem@netsun.com
- 单位地址：上海浦东金湘路201弄15号禹洲金桥国际3期1号楼1102室
- 邮政编码：200120
